PF
Insider
Phillip G. Febbo
Chief Scientific & Med OfficerPhillip G. Febbo (Chief Scientific & Med Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $564K of VCYT (13,110 sh across 2 lots, as filed), executed Sep 4.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Sep 4
Filed Sep 4
Median ADV $55.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
VCYTRecent filings
VCYTSALE
Veracyte, Inc.
View filing →
$564K13,110 sh across 2 lots
Exec Sep 4
Filed Sep 4 · 7:54 PM ET VCYTSALE Veracyte, Inc. View filing → $485K
13,425 sh × $36.16
Exec Mar 2
Filed Mar 4 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $301K
8,349 sh × $36.02
Exec Oct 6 2025
Filed Oct 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $268K
8,037 sh across 2 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $173K
3,934 sh × $44.09
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET